How to treat testicular cancer

Testicular cancer is a disease that occurs in the testicular tissue of men. There are many causes of the disease, and it is also related to diet and lifestyle habits. Testicular cancer has a huge impact on male fertility. Timely treatment of testicular cancer is the key. So how to treat testicular cancer? Here are a few treatment methods for testicular cancer for your reference.

The main treatments for testicular cancer are:

1. Surgical treatment

Because the pathology of testicular tumors is extremely complex, there is no consensus on the treatment method. However, no matter which type of testicular tumor, orchiectomy should be performed first, and further treatment will be determined based on the results of pathological examination.

1) Orchiectomy

2) Retroperitoneal lymph node dissection

2. Radiation therapy

Radiotherapy alone can be used for clinical stage I and IIa (maximum diameter of retroperitoneal metastatic lymph nodes less than 2cm), and combined radiotherapy and surgery can be used for stage IIb. Radiotherapy has similar efficacy to retroperitoneal lymph node dissection, but has less damage to sexual function. Combined treatment with radiotherapy and surgery may cause more damage to sexual function, so currently chemotherapy and surgery are more advocated, and combined treatment with radiotherapy and surgery is not advocated. No preventive irradiation of the mediastinum and supraclavicular region is performed in clinical stage II. What should I do if I have testicular cancer?

3. Chemotherapy

The complete remission rate of DDP-based combined chemotherapy for disseminated testicular germ cell cancer is 80%. Incomplete remission patients can receive rescue chemotherapy, and 30% of patients can still achieve complete remission; 90% of complete remission patients can survive long-term without cancer. If the serum marker level rises again or the residual mass increases, rescue chemotherapy will be performed. Rescue chemotherapy usually uses DDP + a combination of drugs that have not been used in the first chemotherapy. VIP and VAB-6 are currently commonly used regimens.